Financial Snapshot

Revenue
$40.56M
TTM
Gross Margin
Net Earnings
-$179.3M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
729.39%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$354.3M
Q3 2024
Cash
Q3 2024
P/E
-1.348
Nov 29, 2024 EST
Free Cash Flow
-$172.2M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $0.00 $0.00 $0.00 $0.00 $10.00K
YoY Change -100.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $0.00 $0.00 $0.00 $0.00 $10.00K
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $64.35M $54.55M $40.94M $33.89M $8.460M $4.880M
YoY Change 17.96% 33.25% 20.81% 300.59% 73.36%
% of Gross Profit
Research & Development $189.6M $172.7M $175.6M $84.90M $38.39M $18.92M
YoY Change 9.76% -1.63% 106.83% 121.18% 102.89%
% of Gross Profit
Depreciation & Amortization $1.400M $1.400M $500.0K $200.0K $111.0K $50.00K
YoY Change 0.0% 180.0% 150.0% 80.18% 122.0%
% of Gross Profit
Operating Expenses $299.5M $227.3M $216.5M $118.8M $46.85M $23.80M
YoY Change 31.78% 4.96% 82.29% 153.57% 96.83%
Operating Profit -$299.5M -$227.3M -$216.5M -$118.8M -$46.85M
YoY Change 31.78% 4.96% 82.29% 153.57%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense $22.62M $5.987M $401.0K $680.0K $500.0K $360.0K
YoY Change 277.77% 1393.02% -41.03% 36.0% 38.89%
% of Operating Profit
Other Income/Expense, Net -$20.00K $0.00
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$292.9M -$237.6M -$164.6M -$118.1M -$46.36M -$23.43M
YoY Change 23.29% 44.37% 39.33% 154.74% 97.88%
Income Tax -$601.0K -$469.0K -$297.0K $444.0K $15.00K $0.00
% Of Pretax Income
Net Earnings -$292.2M -$236.8M -$158.7M -$117.8M -$45.66M -$21.07M
YoY Change 23.39% 49.19% 34.69% 158.07% 116.72%
Net Earnings / Revenue -210700.0%
Basic Earnings Per Share -$4.47 -$4.48 -$3.72 -$4.19
Diluted Earnings Per Share -$4.47 -$4.48 $0.00 $0.00 -$8.16 -$610.7K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $482.9M $437.4M $339.9M $338.5M $67.20M $25.20M
YoY Change 10.41% 28.68% 0.41% 403.72% 166.67%
Cash & Equivalents $28.04M $43.07M $59.71M $55.00M $67.20M $25.20M
Short-Term Investments $454.9M $394.3M $280.2M $283.6M
Other Short-Term Assets $10.46M $8.180M $10.88M $6.200M $1.500M $600.0K
YoY Change 27.9% -24.81% 75.47% 313.33% 150.0%
Inventory
Prepaid Expenses
Receivables $4.000K $400.0K $100.0K $900.0K
Other Receivables $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $496.7M $451.9M $350.8M $345.1M $68.90M $26.70M
YoY Change 9.91% 28.84% 1.64% 400.87% 158.05%
Property, Plant & Equipment $41.74M $50.08M $52.84M $3.600M $2.800M $300.0K
YoY Change -16.66% -5.23% 1367.75% 28.57% 833.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $21.21M $37.50M
YoY Change -100.0% -43.42%
Other Assets $9.499M $12.35M $9.667M $4.300M $3.200M $1.500M
YoY Change -23.09% 27.75% 124.81% 34.38% 113.33%
Total Long-Term Assets $54.97M $87.38M $103.7M $20.50M $18.60M $14.30M
YoY Change -37.09% -15.77% 406.03% 10.22% 30.07%
Total Assets $551.7M $539.3M $454.5M $365.6M $87.50M $41.00M
YoY Change
Accounts Payable $14.93M $11.25M $11.59M $8.700M $4.300M $3.400M
YoY Change 32.71% -2.96% 33.22% 102.33% 26.47%
Accrued Expenses $54.16M $45.02M $31.38M $19.50M $10.60M $2.600M
YoY Change 20.31% 43.44% 60.94% 83.96% 307.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $69.37M $56.65M $43.94M $28.60M $14.90M $6.200M
YoY Change 22.45% 28.91% 53.65% 91.95% 140.32%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $44.93M $47.79M $44.46M $1.100M $1.700M $0.00
YoY Change -5.98% 7.48% 3941.73% -35.29%
Total Long-Term Liabilities $44.93M $47.79M $44.46M $1.100M $1.700M $0.00
YoY Change -5.98% 7.48% 3941.73% -35.29%
Total Liabilities $114.4M $105.5M $90.55M $57.00M $25.90M $16.20M
YoY Change 8.43% 16.51% 58.86% 120.08% 59.88%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 65.41M shares 52.86M shares 42.69M shares 28.11M shares 5.597M shares
Diluted Shares Outstanding 65.41M shares 52.86M shares 42.69M shares 28.11M shares 5.597M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $241.59 Million

About Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. The company is headquartered in San Diego, California and currently employs 168 full-time employees. The company went IPO on 2020-04-03. The firm is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The firm is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The firm is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.

Industry: Pharmaceutical Preparations Peers: CHINOOK THERAPEUTICS, INC. Akero Therapeutics, Inc. VERACYTE, INC. Deciphera Pharmaceuticals, Inc. FIBROGEN INC Gossamer Bio, Inc. Kymera Therapeutics, Inc. RHYTHM PHARMACEUTICALS, INC. SpringWorks Therapeutics, Inc.